115144-40-6

Basic information

• Product Name: 3,4-Difluoroanisole
• Synonyms: 3,4-DIFLUORO-1-METHOXYBENZENE;3,4-DIFLUOROANISOLE;1,2-DIFLUORO-4-METHOXY-BENZENE;3,4-Difluoroanisole 98%;3,4-Difluoroanisole98%;3,4,5-TRIFLUORO ANISOLE;1,2-Difluoro-4-methoxybenzene, 3,4-Difluorophenyl methyl ether;Benzene, 1,2-difluoro-4-methoxy-
• CAS NO: 115144-40-6
• Molecular Formula: C₇H₆F₂O
• Molecular Weight: 144.12
• Product Categories: Aromatic Ethers;Anisole;Anisoles, Alkyloxy Compounds & Phenylacetates;Fluorine Compounds;Ethers;Organic Building Blocks;Oxygen Compounds;Pyridines
• Mol File: 115144-40-6.mol

Chemical Properties

• Boiling Point: 101.45°C (rough estimate)
• Flash Point: 131 °F
• Appearance: Clear colorless/Liquid
• Density: 1.216 g/mL at 25 °C(lit.)
• Refractive Index: n20/D 1.469(lit.)
• Storage Temp.: Sealed in dry,Room Temperature
• BRN: 6717610
• CAS DataBase Reference: 3,4-Difluoroanisole(CAS DataBase Reference)
• NIST Chemistry Reference: 3,4-Difluoroanisole(115144-40-6)
• EPA Substance Registry System: 3,4-Difluoroanisole(115144-40-6)

Safety Data

• Hazard Codes: Xi,F,Xn
• Statements: 10-36/37/38
• Safety Statements: 16-26-36-7/9
• RIDADR: UN 1993 3/PG 3
• WGK Germany: 3
• HazardClass: 3
• PackingGroup: III
• Hazardous Substances Data: 115144-40-6(Hazardous Substances Data)

Usage

Chemical Properties

CLEAR COLOURLESS LIQUID

Upstream product

• 2713-33-9 3,4-difluorophenol 
• 74-88-4 methyl iodide 

Downstream Products

• 187543-87-9 2,3-difluoro-6-methoxybenzaldehyde 
• 248275-62-9 cyclopent-3-enyl-(2,3-difluoro-6-methoxy-phenyl)-methanol 
• 248275-63-0 2-Cyclopent-3-enylmethyl-3,4-difluoro-1-methoxy-benzene 
• 248275-64-1 2-Cyclopent-3-enylmethyl-3,4-difluoro-phenol 
• 248275-65-2 trifluoro-methanesulfonic acid 2-cyclopent-3-enylmethyl-3,4-difluoro-phenyl ester 
• 922166-24-3 (+)-N-benzyl-5,6-difluoro-11-azatricyclo[7.3.1.0^2,7]trideca-2⁽⁷⁾,3,5-triene 
• 476199-03-8 7-fluoro-4-methoxy-1-benzothiophene-2-carboxylic acid 
• 476199-02-7 methyl 7-fluoro-4-methoxy-1-benzothiophene-2-carboxylate 
• 476199-75-4 4-(3-chloro-1-phenyl-propoxy)-7-fluoro-benzo[b]thiophene 
• 476199-46-9 4-(3-chloro-1-phenyl-propoxy)-7-fluoro-benzo[b]thiophene 
• 910394-72-8 2,3-difluoro-6-methoxyphenethylamine 
• 181305-41-9 1-(5-Bromo-pyridin-2-yl)-3-[2-(2,3-difluoro-6-methoxy-phenyl)-ethyl]-thiourea 
• 836678-96-7 1-fluoro-4-methoxy-2-methylsulphanyl-benzene 
• 303044-01-1 1-chloromethyl-4,5-difluoro-2-methoxy-benzene 

Relevant articles and documents

Discovery of novel selective GPR120 agonists with potent anti-diabetic activity by hybrid design

GPR120 is an attractive target for the treatment of type 2 diabetes. In this study, a series of biphenyl derivatives were designed, synthesized by hybrid design. The selected compound 6a exhibited potent GPR120 agonist activity (EC50 = 93 nM) and high selectivity over GPR40. The results of oral glucose tolerance test (OGTT) demonstrated that 6a exhibited significant glucose-lowering effect in glucose-loaded ICR male mice. Analysis of the structure–activity relationship is also presented. Compound 6a deserves further biological evaluation and structural modifications.

Method for preparing 3,4-difluoroanisole

The method discloses a method for preparing 3,4-difluoroanisole. The method includes the steps that compound 3,4-difluorophenol is dissolved in acetonitrile, potassium carbonate is weighed, methyl iodide is dripped, and the mixture is reacted overnight at

Silver-mediated fluorination of potassium aryltrifluoroborates with Selectfluor Dedicated to Professor Andrea Vasella on the occasion of his 71st birthday

A simple and practical procedure for the silver-mediated fluorination of aryl- and heteroaryltrifluoroborates with electrophilic fluorine from Selectfluor and LiOH·H2O is presented. The reaction procedure is simple and easy to set up, the process produces fluorinated arenes and heteroarenes in good to excellent yields and a wide range of electronically and structurally diverse substrates are tolerated.

Phenethylthiazolylthiourea (PETT) compounds as a new class of HIV-1 reverse transcriptase inhibitors. 2. Synthesis and further structure-activity relationship studies of PETT analogs

Phenylethylthiazolylthiourea (PETT) derivatives have been identified as a new series of nonnucleoside inhibitors of HIV-1 RT. Structure-activity relationship studies of this class of compounds resulted in the identification of N-[2-(2-pyridyl)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea hydrochloride (trovirdine; LY300046.HCl) as a highly potent anti-HIV-1 agent. Trovirdine is currently in phase one clinical trials for potential use in the treatment of AIDS. Extension of these structure-activity relationship studies to identify additional compounds in this series with improved properties is ongoing. A part of this work is described here. Replacement of the two aromatic moleties of the PETT compounds by various substituted or unsubstituted heteroaromatic rings was investigated. In addition, the effects of multiple substitution in the phenyl ring were also studied. The antiviral activities were determined on wild-type and constructed mutants of HIV-1 RT and on wild-type HIV-1 and mutant viruses derived thereof, Ile100 and Cys181, in cell culture assays. Some selected compounds were determined on double- mutant viruses, HIV-1 (Ile100/Asn103) and HIV-1 (Ile100/Cys181). A number of highly potent analogs were synthesized. These compounds displayed IC50's against wild-type RT between 0.6 and 5 nM. In cell culture, these agents inhibited wild-type HIV-1 with ED50's between I and 5 nM in MT-4 cells. In addition, these derivatives inhibited mutant HIV-1 RT (Ile 100) with IC50's between 20 and 50 nM and mutant HIV-1 RT (Cys 181) with IC50's between 4 and 10 nM, and in cell culture they inhibited mutant HIV-1 (Ile100) with ED50's between 9 and 100 nM and mutant HIV-1 (Cys181) with ED50's between 3 and 20 nM.